Literature DB >> 20058257

Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults?

Zhiqiang Wang1, Qin Zhuo, Ping Fu, Jiahua Piao, Yuan Tian, Jie Xu, Xiaoguang Yang.   

Abstract

BACKGROUND: China has experienced a rapid increase in diabetes. In this study, we assessed whether the associations of two adipocyte-derived hormones, leptin and adiponectin, with type 2 diabetes are independent of obesity in older Chinese adults.
METHODS: In this matched case-control study, each of the 619 diabetes and impaired fasting glucose (IFG) cases aged 60-96 years was matched to a control by age, sex, waist circumference and body mass index (BMI).
RESULTS: Before matching, IFG and diabetes cases had significantly lower adiponectin and higher leptin concentrations than the participants with normal glucose. After matching for age, sex, waist circumference and BMI, the differences between cases and controls remained significant (p < 0.001) in adiponectin but not in leptin (p = 0.77). Adjusted odds ratios for the combined outcome of diabetes and IFG were 1.03 (95% confidence interval: 0.88, 1.21; p = 0.71) for one standard deviation increase in plasma leptin and 0.79 (95% confidence interval: 0.69, 0.91; p < 0.001) for one standard deviation increase in plasma adiponectin.
CONCLUSION: Without adjustment for obesity related body size measurements of waist circumference and BMI, both adiponectin and leptin are associated with diabetes and IFG. After adjustment, adiponectin is independently associated with diabetes and IFG, but there is no independent association between leptin and either diabetes or IFG. Our findings suggest that adiponectin provides extra-predictive power beyond obesity while leptin does not independently predict the risk of diabetes and IFG in older Chinese adults. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20058257     DOI: 10.1002/dmrr.1060

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  7 in total

1.  Leptin partially mediates the association between early-life nutritional supplementation and long-term glycemic status among women in a Guatemalan longitudinal cohort.

Authors:  Siran He; Ngoc-Anh Le; Manuel Ramirez-Zea; Reynaldo Martorell; K M Venkat Narayan; Aryeh D Stein
Journal:  Am J Clin Nutr       Date:  2020-04-01       Impact factor: 7.045

2.  Adiponectin is Associated with Impaired Fasting Glucose in the Non-Diabetic Population.

Authors:  Sang Yeun Kim; Sun Ju Lee; Hyoun Kyoung Park; Ji Eun Yun; Myoungsook Lee; Jidong Sung; Sun Ha Jee
Journal:  Epidemiol Health       Date:  2011-08-20

3.  Genomic and epigenomic responses to chronic stress involve miRNA-mediated programming.

Authors:  Olena Babenko; Andrey Golubov; Yaroslav Ilnytskyy; Igor Kovalchuk; Gerlinde A Metz
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

4.  Effect of adiponectin level and genetic variation of its receptors on diabetic retinopathy: A case-control study.

Authors:  Wen-Ling Liao; Yung-Hsiang Chen; Ching-Chu Chen; Yu-Chuen Huang; Hui-Ju Lin; Yng-Tay Chen; Bo Ban; Chia-Ming Wu; Ya-Wen Chang; Ai-Ru Hsieh; Fuu-Jen Tsai
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

5.  Association between serum leptin concentrations and insulin resistance: a population-based study from China.

Authors:  Hui Zuo; Zumin Shi; Baojun Yuan; Yue Dai; Gaolin Wu; Akhtar Hussain
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

6.  Comparison of salivary and plasma adiponectin and leptin in patients with metabolic syndrome.

Authors:  Supanee Thanakun; Hisashi Watanabe; Sroisiri Thaweboon; Yuichi Izumi
Journal:  Diabetol Metab Syndr       Date:  2014-02-14       Impact factor: 3.320

Review 7.  Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.

Authors:  Bingxuan Wang; P Charukeshi Chandrasekera; John J Pippin
Journal:  Curr Diabetes Rev       Date:  2014-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.